MENU
APR 21 - 23 2020

Genetics Virtual Week 2020


LabRoots is excited to announce our 8th Annual Genetics Virtual Week held on April 21-23, 2020!

Genetics Virtual Week 2020 will offer a multi-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology and human health, Molecular Diagnostics, exploring best laboratory practices and novel diagnostic applications, and Precision Medicine, spanning innovative technologies and solutions transforming healthcare and changing how patients are treated today.  

Over the three days, invited lectures, thought-provoking discussions, and posters will be presented by academia and industry experts, professionals in medical and clinical genetics, scientific leaders, and research scholars.

This years Genetics Virtual Week will include the following topics:

Genetics and Genomics

Genome Editing

  • Latest Genome Editing Techniques and Applications
  • Measuring the Outcomes of Genome Editing Experiments & Characterizing Undesired Editing Effects

The Evolution of Genome Reference Concepts

  • Latest Techniques for Creating Reference-Quality Genomes
  • Analysis and Implications of Pan Genomes

Single Cell and Spatial Genomics

  • Full-length RNA sequencing with Single-Cell Resolution

Structural Variation

  • Latest Methods & Analysis Tools for Characterizing Structural Genomic Variation
  • Structural Genetic Variation in the Global Human Population
  • Implementation of WGS-SV Calling in Monogenic Rare Diseases

Human Genomic Evolution

Molecular Diagnostics

Point of Care Testing

  • Quality
  • Accessibility
  • Cost/Reimbursement
  • Disruptive POC Devices

Emerging Technologies in Molecular Diagnostics

  • Liquid Biopsy
  • CRISPR Diagnostics
  • Digital PCR
  • Omics-based Biomarker Discovery
  • Clinical metagenomics

Artificial Intelligence

  • CDS Tools in Molecular Diagnostics
  • ML based Clinical Algorithms in Cancer Genetics
  • Role of AI in Genomics

Precision Medicine

Rare Disease in Precision Medicine

Precision Medicine in Clinic

  • Next-Generation Sequencing Technologies - The long and the short of it

Molecular Profiling - from Bench to Bedside

 

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Enjoy the interactive environment via live-streaming video and chat sessions with peers, and using the Leaderboard and Gamification to move around the entire event, earning points for a chance to win one of LabRoots most popular t-shirts.


Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Genetics Virtual Week. Submit your free abstract here.

Continuing Education – LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits. This event will also provide CEU's for Genetic Counselors and is pending approval by the NSGC.

Use #LRgenetics to follow the conversation!


Speakers

Show Resources
You May Also Like
JUL 29, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 29, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Immuno-Oncology & Cancer Biology The rapid development of immuno-oncology therapies has transformed the cancer treatment landscape. Discovering safe, potent, and persistent immune cell p...
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 1st Annua...
OCT 07, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
OCT 07, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots and the Cancer Research and Oncology Planning Committee are pleased to announce the 8th Annual Cancer Research and Oncology Virtual Event! This 2-day event will take place on October...
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots and the Cell Biology Planning Committee are please to announce the 4th Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological researc...
Presentations
  • Keynote Presentation: Systematic identification of therapeutic strategies that leverage tumor evolution
    APR 23, 2020 10:30 AM PDT
    Kris C. Wood
    Assistant Professor, Department of Pharmacology and Cancer Biology, Duke University
  • Keynote Presentation: Individualized Health
    APR 23, 2020 9:00 AM PDT
    Michael Snyder, PhD
    Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine
  • Keynote Presentation: The Massively Parallel Sequencing (MPS) Revolution
    APR 23, 2020 7:30 AM PDT
    David Smith, PhD
    Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic
  • Latest Applications of PacBio Sequencing for Clinical Research
    APR 23, 2020 6:00 AM PDT
    Jonas Korlach, PhD
    Chief Scientific Officer, Pacific Biosciences
    Sponsored By: PacBio
  • From Data to Biological Insight using QIAGEN OmicSoft and IPA: Single Cell Sequencing of Normal Human Liver
    APR 22, 2020 9:00 AM PDT
    Jean-Noel Billaud, PhD
    Principal Scientist, QIAGEN Bioinformatics
    Sponsored By: QIAGEN
  • Improved Genome Editing Using Single-Stranded DNA
    APR 22, 2020 6:00 AM PDT
    Ye Chen, PhD
    Associate Director of Research and Development for GENEWIZ
    Sponsored By: GENEWIZ
  • Aggregating and Sharing Clinical Evidence to Improve the Diagnosis of Rare Diseases
    Ben Liesfeld, PhD
    Co-Founder and Managing Director, Limbus Medical Technologies
  • Clinical Applications of Estrogen Metabolism Genetic Testing: Improving Estrogen Health, Preventing Breast Cancer and Prescribing Estrogenic Medications with Precision
    T.J. Hills
    Breast Cancer Prevention Advocate & Author
  • Genomic Landscapes: Leveraging Genetic Evidence throughout the Pharma Pipeline
    Mark Kiel, MD, PhD
    Co-Founder and Chief Science Officer, Genomenon
  • Long-range technologies resolve complex genomic regions overlooked by short-read sequencing
    Mark Ebbert, PhD
    Mayo Clinic
  • Nanotherapeutics: An insight into healthcare and future multi-dimensional clinical applications
    Pratibha Kakadia, PhD
    Research Affiliate, Integrative Behavioural Health Research Institute
  • Population Health and Genetic Testing
    Matthew J. Ferber, PhD, FACMG
    Associate professor and consultant in the Department of Laboratory Medicine and Pathology, Founder and director of the Clinical Genome Sequencing Laboratory at Mayo
  • Precision Infectious Disease Diagnostics Using Next-Generation Sequencing and AI
    Dorottya Nagy-Szakal, MD PhD
    Chief Medical Officer, Biotia, Inc.
  • Priming the Precision Medicine Pipeline: New Models for Applied Genomics Education
    Barbara Kraatz Fortini, PhD
    Program Director, MS in Human Genetics and Genomic Data Analytics, Assistant Professor of Genetics, School of Pharmacy and Health Sciences at the Keck Graduate Institute
  • RNA-seq for the Detection of Gene Fusions in Tumors
    Kevin Halling, MD, PhD
    Mayo Clinic
  • Rapid Diagnosis of Complex Rare Disease Cases Using Exome Sequencing
    Louisa Ive, MSc HCPC
    Clinical Scientist, Congenica
  • The Cardean Transistor Infrastructure: using cloud-analysis software and "lab on a chip" technology to develop handheld readers for rapid virus detection
    Brett Goldsmith, PhD
    Co-Founder and CTO, Cardea Bio
  • APR 21, 2020 1:30 PM PDT
    Dina Finan, PhD
    Product Manager, 10x Genomics
    Stephen Williams, PhD
    Senior Computational Biologist, 10x Genomics
  • Expanding the Hi-C toolbox: New high-resolution approaches for diploid genome phasing, protein-directed chromatin architecture mapping and more
    APR 21, 2020 12:00 PM PDT
    Iain Russell, PhD
    Associate Director of Marketing
    Sponsored By: Dovetail Genomics
  • SNVs to Large Structural Variation: Capturing nucleotide through inter-chromosomal variants through a powerful three-dimensional data type
    Cory Padilla, PhD
    Research & Development team, Leading Scientific Affairs, Dovetail Genomics
  • Long HiFi Reads for High-Quality Genome Assemblies
    APR 21, 2020 10:30 AM PDT
    Jonas Korlach, PhD
    Chief Scientific Officer, Pacific Biosciences
    Sponsored By: PacBio
  • Optimizing human karyomapping to phase single lgene defects with improved DNA amplification
    APR 21, 2020 10:30 AM PDT
    Samuel Rulli, PhD
    Senior Global Product Manager, RNA Profiling , QIAGEN
    Sponsored By: QIAGEN
  • Novel CRISPR Knock-In Technology for the Robust Analysis of Cells and Tissue
    APR 21, 2020 7:30 AM PDT
    Scott H. Soderling, PhD
    Founder and CSO, CasTag Biosciences Chair and Professor of Cell Biology, Duke University
    Sponsored By: CasTag Biosciences
  • Advantages of digital PCR and its applications - the power of partitioning
    APR 21, 2020 6:00 AM PDT
    Daniel Heinz Löfgren, MSc.
    Market Development Manager PCR/dPCR EMEA
    Sponsored By: QIAGEN
  • PRINCESS: A Framework for Comprehensive Detection and Haplotype Phasing of SNPs and Structural Variants
    Medhat Mahmoud, PhD
    Baylor College of Medicine
  • Bionano Genome Imaging: unbiased, genome-wide structural variation detection in genetic disease and cancer, down to 1% allele fraction
    Sven Bocklandt, PhD
    Sr. Director of Scientific Affairs & Marketing, Bionano Genomics
  • Contribution of transposons to structural variation and phenotypic diversity in tomato
    Matthias Benoit, PhD
    Research Associate, Lippman Lab, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory
  • Single Cell Multi-omics: Solving the Jigsaw
    Ivan K. Lukić, MD, PhD
    Senior Field Application Scientist, Partek
  • Single cell gene expression: new insights through the lens of full length mRNA isoform resolution
    Jason G. Underwood, PhD
    Principal Scientist
  • Genomics
    • Genome Editing
    • Novel CRISPR Knock-In Technology for the Robust Analysis of Cells and Tissue
      APR 21, 2020 7:30 AM PDT
      Scott H. Soderling, PhD
      Founder and CSO, CasTag Biosciences Chair and Professor of Cell Biology, Duke University
      Sponsored By: CasTag Biosciences
    • Improved Genome Editing Using Single-Stranded DNA
      APR 22, 2020 6:00 AM PDT
      Ye Chen, PhD
      Associate Director of Research and Development for GENEWIZ
      Sponsored By: GENEWIZ
    • Single Cell
    • Optimizing human karyomapping to phase single lgene defects with improved DNA amplification
      APR 21, 2020 10:30 AM PDT
      Samuel Rulli, PhD
      Senior Global Product Manager, RNA Profiling , QIAGEN
      Sponsored By: QIAGEN
    • Single Cell and Spatial Genomics
    • Single cell gene expression: new insights through the lens of full length mRNA isoform resolution
      Jason G. Underwood, PhD
      Principal Scientist
    • Single Cell Multi-omics: Solving the Jigsaw
      Ivan K. Lukić, MD, PhD
      Senior Field Application Scientist, Partek
    • APR 21, 2020 1:30 PM PDT
      Dina Finan, PhD
      Product Manager, 10x Genomics
      Stephen Williams, PhD
      Senior Computational Biologist, 10x Genomics
    • From Data to Biological Insight using QIAGEN OmicSoft and IPA: Single Cell Sequencing of Normal Human Liver
      APR 22, 2020 9:00 AM PDT
      Jean-Noel Billaud, PhD
      Principal Scientist, QIAGEN Bioinformatics
      Sponsored By: QIAGEN
    • Structural Variation
    • Contribution of transposons to structural variation and phenotypic diversity in tomato
      Matthias Benoit, PhD
      Research Associate, Lippman Lab, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory
    • Bionano Genome Imaging: unbiased, genome-wide structural variation detection in genetic disease and cancer, down to 1% allele fraction
      Sven Bocklandt, PhD
      Sr. Director of Scientific Affairs & Marketing, Bionano Genomics
    • PRINCESS: A Framework for Comprehensive Detection and Haplotype Phasing of SNPs and Structural Variants
      Medhat Mahmoud, PhD
      Baylor College of Medicine
    • SNVs to Large Structural Variation: Capturing nucleotide through inter-chromosomal variants through a powerful three-dimensional data type
      Cory Padilla, PhD
      Research & Development team, Leading Scientific Affairs, Dovetail Genomics
    • The Evolution of Genome Reference Concepts
    • Long HiFi Reads for High-Quality Genome Assemblies
      APR 21, 2020 10:30 AM PDT
      Jonas Korlach, PhD
      Chief Scientific Officer, Pacific Biosciences
      Sponsored By: PacBio
  • Expanding the Hi-C toolbox: New high-resolution approaches for diploid genome phasing, protein-directed chromatin architecture mapping and more
    APR 21, 2020 12:00 PM PDT
    Iain Russell, PhD
    Associate Director of Marketing
    Sponsored By: Dovetail Genomics
  • Molecular Diagnostics
    • Emerging Technologies in Molecular Diagnostics
    • Advantages of digital PCR and its applications - the power of partitioning
      APR 21, 2020 6:00 AM PDT
      Daniel Heinz Löfgren, MSc.
      Market Development Manager PCR/dPCR EMEA
      Sponsored By: QIAGEN
    • Precision Infectious Disease Diagnostics Using Next-Generation Sequencing and AI
      Dorottya Nagy-Szakal, MD PhD
      Chief Medical Officer, Biotia, Inc.
    • The Cardean Transistor Infrastructure: using cloud-analysis software and "lab on a chip" technology to develop handheld readers for rapid virus detection
      Brett Goldsmith, PhD
      Co-Founder and CTO, Cardea Bio
  • Precision Medicine
    • Molecular Profiling - From Bench to Bedside
    • Genomic Landscapes: Leveraging Genetic Evidence throughout the Pharma Pipeline
      Mark Kiel, MD, PhD
      Co-Founder and Chief Science Officer, Genomenon
    • Molecular Profiling - from Bench to Bedside
    • Priming the Precision Medicine Pipeline: New Models for Applied Genomics Education
      Barbara Kraatz Fortini, PhD
      Program Director, MS in Human Genetics and Genomic Data Analytics, Assistant Professor of Genetics, School of Pharmacy and Health Sciences at the Keck Graduate Institute
    • Precision Medicine in Clinic
    • Population Health and Genetic Testing
      Matthew J. Ferber, PhD, FACMG
      Associate professor and consultant in the Department of Laboratory Medicine and Pathology, Founder and director of the Clinical Genome Sequencing Laboratory at Mayo
    • RNA-seq for the Detection of Gene Fusions in Tumors
      Kevin Halling, MD, PhD
      Mayo Clinic
    • Long-range technologies resolve complex genomic regions overlooked by short-read sequencing
      Mark Ebbert, PhD
      Mayo Clinic
    • Nanotherapeutics: An insight into healthcare and future multi-dimensional clinical applications
      Pratibha Kakadia, PhD
      Research Affiliate, Integrative Behavioural Health Research Institute
    • Latest Applications of PacBio Sequencing for Clinical Research
      APR 23, 2020 6:00 AM PDT
      Jonas Korlach, PhD
      Chief Scientific Officer, Pacific Biosciences
      Sponsored By: PacBio
    • Keynote Presentation: The Massively Parallel Sequencing (MPS) Revolution
      APR 23, 2020 7:30 AM PDT
      David Smith, PhD
      Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic
    • Keynote Presentation: Systematic identification of therapeutic strategies that leverage tumor evolution
      APR 23, 2020 10:30 AM PDT
      Kris C. Wood
      Assistant Professor, Department of Pharmacology and Cancer Biology, Duke University
    • Rare Disease in Precision Medicine
    • Rapid Diagnosis of Complex Rare Disease Cases Using Exome Sequencing
      Louisa Ive, MSc HCPC
      Clinical Scientist, Congenica
    • Aggregating and Sharing Clinical Evidence to Improve the Diagnosis of Rare Diseases
      Ben Liesfeld, PhD
      Co-Founder and Managing Director, Limbus Medical Technologies
    • Clinical Applications of Estrogen Metabolism Genetic Testing: Improving Estrogen Health, Preventing Breast Cancer and Prescribing Estrogenic Medications with Precision
      T.J. Hills
      Breast Cancer Prevention Advocate & Author
    • Keynote Presentation: Individualized Health
      APR 23, 2020 9:00 AM PDT
      Michael Snyder, PhD
      Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine
Speakers

  • Michael Snyder, PhD
    Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine
    Biography
      Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and multiomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor (TF) binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated (e.g. lncRNAs and TF binding sites), and a high diversity of transcription factor binding occurs both between and within species. He has also combined different state-of-the-art "omics" technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a cofounder of many biotechnology companies, including Excelix, Personalis, SensOmics, Qbio, January, Protos, Oralome, Mirvie and Filtricine.
    • David Smith, PhD
      Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic
      Biography
        David I Smith received his Ph.D. in Biochemistry from the University of Wisconsin in Madison in 1978 studying antibiotic resistance in bacteria. After doing post-doctoral work first at the Albert Einstein College of Medicine and then at the University of California, Irvine, he got his first faculty position at Wayne State University in 1985. In 1996 he joined the Mayo Clinic as a full Professor in the Department of Laboratory Medicine and Pathology. His laboratory studies the common fragile sites which are regions of profound genomic instability that are found in all individuals. His laboratory also studies the various ways that human papillomavirus is involved in the generation of different cancers. Dr. Smith is also the Chairman of the Technology Assessment Group for the Mayo Clinic Center for Individualized Medicine. The role of this group is to evaluate new technologies that could have a profound impact on basic research and its' clinical translation. The most exciting technology that has the greatest potential to change both research and clinical practice is next generation sequencing and Dr. Smith and his group have been using this technology to answer scientific questions. The advances in next generation sequencing over the past 10 years have been nothing short of incredible and it is now possible to generate terrabases of DNA sequence in a single run of a next generation sequencer. This technology can be utilized in a number of ways from characterizing just a few genes all the way to whole genome sequencing.
      • Matthias Benoit, PhD
        Research Associate, Lippman Lab, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory
        Biography
          Matthias is an HHMI post-doctoral fellow working in Zach Lippman's group at Cold Spring Harbor Laboratory (New York, USA). He completed a PhD in Molecular Genetics and Physiology with Aline V. Probst at Clermont Auvergne University (France), where he studied histone variants and chromatin dynamics during early seedling development in Arabidopsis. He then joined Jurek Paszowski's group at the Sainsbury Laboratory (University of Cambridge, UK) to characterize transposons subjected to developmental and environmental activation in tomato. Matthias' current and future research aim at understanding the significance of genomic and epigenetic variation in tomato development and breeding.
        • Jean-Noel Billaud, PhD
          Principal Scientist, QIAGEN Bioinformatics
          Biography
            Jean-Noel Billaud, Ph.D. is Principal Scientist at QIAGEN Bioinformatics. He joined Ingenuity Systems (now QIAGEN) in 2008 as staff scientist for in silico research program in oncology and infectious diseases. Jean-Noel Billaud holds a Ph.D. in Blood Cell Biology from Paris VII, and has done his post-doctoral work at the Scripps Research Institute (San Diego, CA).
          • Sven Bocklandt, PhD
            Sr. Director of Scientific Affairs & Marketing, Bionano Genomics
            Biography
              Dr. Sven Bocklandt is a human geneticist with a background in gene discovery. He received his PhD from the University of Antwerp, Belgium, based on research on the genetic components of brain sexual differentiation performed at the National Cancer Institute, and at the University of California Los Angeles. As Director of Scientific Affairs and Marketing at Bionano Genomics, he focuses on the scientific discoveries made on the Bionano platform and on Bionano's performance in genetic disease and cancer diagnostics.
            • Ye Chen, PhD
              Associate Director of Research and Development for GENEWIZ
              Biography
                Dr. Chen serves as Associate Director of Research and Development for GENEWIZ and has been working on various projects involving NGS and gene editing services. Dr. Chen received his Ph.D. from Max Planck Institute in Germany, where his research was focused on neuroscience. He also worked as a post-doctoral researcher in Biophysics and Immunology at Swinburne University in Australia.
              • Mark Ebbert, PhD
                Mayo Clinic
                Biography
                  Dr. Ebbert is an Assistant Professor of Neuroscience at the Mayo Clinic with a background in computational biology and bioinformatics, focusing on Alzheimer's disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD). He is employing long-range technologies to identify functional structural DNA variants and individual RNA isoforms driving disease. Dr. Ebbert also has experience in genomics studies and analyses, algorithm design, and statistics. He has published in respected journals across cancer, bioinformatics, ALS, and Alzheimer's disease.
                • Matthew J. Ferber, PhD, FACMG
                  Associate professor and consultant in the Department of Laboratory Medicine and Pathology, Founder and director of the Clinical Genome Sequencing Laboratory at Mayo
                  Biography
                    Dr. Matthew Ferber is an associate professor and consultant in the Department of Laboratory Medicine and Pathology serving as a Co-Director for the Genomics Laboratory since 2005. He was the founder and director of the Clinical Genome Sequencing Laboratory at Mayo from 2012 to 2018. He has worked very closely with Mayo Clinic's Center for Individualized Medicine over the years serving as a founding member of the Clinomics program, which created the Individualized Medicine Clinic and Mayo's Diagnostic Odyssey Services. In October 2018 under the leadership of Dr. Ferber, Mayo's consumer genomic testing product, Mayo Clinic GeneGuideTM, launched.
                  • Dina Finan, PhD
                    Product Manager, 10x Genomics
                    Biography
                      Dina Finan is a Product Manager at 10x Genomics. Prior to joining 10x, she worked in the field of protein engineering and antibody stability. She received a Ph.D. in Biochemistry at Stanford University studying molecular motor proteins and their role in embryonic development.
                    • Brett Goldsmith, PhD
                      Co-Founder and CTO, Cardea Bio
                      Biography
                        Dr. Brett Goldsmith is the Co-founder and CTO of Cardea Bio and his passion is to apply nanoelectronics technology to products that change people's lives. Previous to Cardea, Brett received his undergraduate in Physics from University of California San Diego and his PhD in Chemical and Material Physics from University of California Irvine. He then continued his postdoctoral studies at University of Pennsylvania, an Intelligence Community Fellow where he focused on research and creation of materials and devices for science, biotechnology, intelligence and defense industries. He is the lead researcher on landmark Field Effect Biosensing papers in Science and Nature Nanotechnology.
                      • Kevin Halling, MD, PhD
                        Mayo Clinic
                        Biography
                          Dr. Halling is a molecular pathologist and a Professor in the Division of Laboratory Genetics. He is a co-director of the Genomics Laboratory which performs molecular oncology and hereditary disorder testing. He received his M.D. and Ph.D. from the University of Kansas and completed an Anatomic and Clinical pathology residency and Clinical Molecular Genetics fellowship at the Mayo Clinic. His primary area of interest is in the development of genetic tests that can be used for the diagnosis and treatment of sporadic and hereditary cancer. He and his team have developed a clinical RNA Seq assay that can be used to detect gene fusions in patients with various types of malignancies and are also working on other clinical applications of RNA-seq and other RNA testing methodologies. Dr. Halling has published over 100 papers that mostly relate to genetic testing of cancer.
                        • T.J. Hills
                          Breast Cancer Prevention Advocate & Author
                          Biography
                            T.J. is the former CEO of the Estrogen Gene Test Co and Author "My Estrogen Breast Cancer Treatment Diary: Improving Estrogen Health", Board Member of Better Estrogen Foundation and the Hormonal Cancer Foundation. She has appeared on National TV, radio outlets across the country and major medical conferences. She has her M.A. from Columbia University. She advocates improving women's estrogen health through personalized nutritional interventions based on modifiable gene testing. This approach also allows physicians guidance in prescribing estrogenic medications.
                          • Louisa Ive, MSc HCPC
                            Clinical Scientist, Congenica
                            Biography
                              Louisa Ive, MSc HCPC, received her undergraduate education at University College London, London and completed her Clinical Scientist training at St George's University Hospital, London. She is a practicing Clinical Scientist, certified by the Health & Care Professions Council and currently working within the Clinical team at Congenica. Her clinical expertise within genetics is broad, however she has a subspecialty interest in pre-implantation and prenatal diagnosis. Her MSc thesis explored extended next generation sequencing testing in colorectal cancer patients. Louisa is a former Chair of the London Healthcare Science Trainee Network, and is a current member of the British Society of Genetic Medicine.
                            • Barbara Kraatz Fortini, PhD
                              Program Director, MS in Human Genetics and Genomic Data Analytics, Assistant Professor of Genetics, School of Pharmacy and Health Sciences at the Keck Graduate Institute
                              Biography
                                Barbara Fortini is Assistant Professor of Genetics and Program Director for the new Master of Science in Human Genetics and Genomic Data Analytics (MSGDA) Program in the School of Pharmacy and Health Sciences at the Keck Graduate Institute, one of the Claremont Colleges in Claremont, CA. Barbara completed her PhD at the California Institute of Technology where her thesis focused on the biochemistry and genetics of genome stability. Barbara undertook her postdoctoral training at the University of Southern California - Keck School of Medicine in the department of Preventive Medicine using post-GWAS functional genomics to understand colorectal cancer risk. Upon her appointment as Assistant Professor of Genetics in KGI's School of Pharmacy and Health Sciences, she worked closely alongside Ashley Mills, Program Director of the new MS in Genetic Counseling, to launch both genetics masters programs in the Fall of 2018. Barbara currently teaches courses in Human Molecular Genetics, Human Genomics with NGS Lab, and Functional Genomics for both programs.
                              • Pratibha Kakadia, PhD
                                Research Affiliate, Integrative Behavioural Health Research Institute
                                Biography
                                  Pratibha Kakadia received her PhD in Pharmaceutical Science from University of Huddersfield, England, UK. Her graduate research was completed in the lab of Prof. Barbara Conway, Ph.D. Her research is focussed on the investigation of design and development of nanoformulations for the targeted delivery of antibacterial drugs for treatment of skin infections. She has worked as Scientist in Merck Research Labs in Pennsylvania, supporting formulation of RNA based lipid nanoparticles delivery for preclinical research. Currently, Pratibha is the Research Affiliate with Integrative Behavioural Health Research Institute, Pasadena, California. She has three-first author publications in the reputed peer-reviewed journals and 2 oral and 10 poster talks on the design and formulation of lipid nanoparticles approach for controlled and targeted drug delivery.
                                • Mark Kiel, MD, PhD
                                  Co-Founder and Chief Science Officer, Genomenon
                                  Biography
                                    Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was more likely to emerge out of industry. In 2014, he founded Genomenon - a life science IT company addressing the challenge of connecting doctors with evidence in the literature to help diagnose patients with genetic diseases and cancer.
                                  • Jonas Korlach, PhD
                                    Chief Scientific Officer, Pacific Biosciences
                                    Biography
                                      Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 100 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                                    • Ben Liesfeld, PhD
                                      Co-Founder and Managing Director, Limbus Medical Technologies
                                      Biography
                                        Dr. Ben Liesfeld is Co-Founder and Managing Director of Limbus Medical Technologies, a medical software company whose mission is to support and facilitate genetic diagnostics. A physicist by training, he co-invented computer guided laser surgery devices for ophthalmology. When accepting a position in a clinical laboratory in 2013 he learned about the huge potential and the challenges of diagnosing rare diseases using next-generation sequencing. This led him to create an independent enterprise to leverage software and real-world evidence in order to solve the puzzles of genetic diseases.
                                      • Daniel Heinz Löfgren, MSc.
                                        Market Development Manager PCR/dPCR EMEA
                                        Biography
                                          Daniel Heinz Löfgren is the Market Development Manager for digital PCR (dPCR) and PCR at QIAGEN for EMEA. He has over 10 years of experience in the field of PCR, qPCR and dPCR, with assay design, different workflows and applications. In addition, he has worked for 5 years as a Field Applications Specialist for droplet digital PCR and qPCR. Furthermore, he has experience working as a Genomics Applications Specialist supporting QIAGEN's NGS workflows.
                                        • Ivan K. Lukić, MD, PhD
                                          Senior Field Application Scientist, Partek
                                          Biography
                                            Dr. Lukić earned his medical degree and doctorate in immunology from the Zagreb University School of Medicine in Croatia and completed his postdoctoral training at the University of Heidelberg in Germany. As a research scientist, he authored or co-authored several dozen manuscripts on multiple roles that the immune system plays in health and disease. In 2011, Dr. Lukić joined Partek as a senior field application scientist where he has since advised hundreds of Partek users across the globe on various aspects of experimental design and data analysis, helping them to present their stories to the world.
                                          • Medhat Mahmoud, PhD
                                            Baylor College of Medicine
                                            Biography
                                              Degree: Ph.D. in Biochemistry, Institute of Bioorganic Chemistry, Polish Academy of Science, Poznań, Poland. Postdoc fellow in Human Genome Sequencing Center, Baylor College of Medicine... Interests: I'm interested in studying genomic variants and their effect, including the development of tools for comprehensive variant analysis (SNVs, SVs, and Methylation).
                                            • Dorottya Nagy-Szakal, MD PhD
                                              Chief Medical Officer, Biotia, Inc.
                                              Biography
                                                Dorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine, pediatrics, gastroenterology, microbiology, and clinical metagenomics. She led cutting-edge clinical trials on fecal microbiome transplantation and developed a multicenter research program to understand the role of the gut-brain axis in the integrative neuroscience field. Currently, Dorottya is the Chief Medical Officer at Biotia, a NYC-based startup focusing on rapid infectious disease diagnostics, surveillance, and prevention of hospital-acquired infections powered by artificial intelligence.
                                              • Cory Padilla, PhD
                                                Research & Development team, Leading Scientific Affairs, Dovetail Genomics
                                                Biography
                                                  Cory received his Ph.D. from Georgia Institute of Technology in cellular and molecular biology and holds a B.S. from the University of California at Santa Cruz. Cory joined Dovetail Genomics in 2017 as part of the Research & Development team and now leads Scientific Affairs. Cory's focus is to act as a liaison between the company and the scientific community. In this role, Cory identifies new research areas, captures feedback on customer needs for integration into product development and works to educate the community on advances and new products from Dovetail Genomics.
                                                • Samuel Rulli, PhD
                                                  Senior Global Product Manager, RNA Profiling , QIAGEN
                                                  Biography
                                                    Samuel Rulli is a Senior Global Product Manager for the QIAseq RNA Profiling Technologies at QIAGEN. Dr. Rulli received his Ph.D. in 2002 from Tulane University studying the gastric proton pump and did post-doctoral research at Johns Hopkins University and the National Cancer Institute in Frederick, MD. He joined SABiosciences - now a part of QIAGEN - in 2007 as an R&D Scientist in qPCR applications and moved to a Global Product Manager role in 2014. Trained as a molecular biologist, Dr. Rulli has worked on different assay detection technologies for gene expression and nucleic acid analysis.
                                                  • Iain Russell, PhD
                                                    Associate Director of Marketing
                                                    Biography
                                                      Iain Russell has over 18 years of experience in the Life Sciences industry and the genomics field. Iain joined Dovetail Genomics in August 2019 and is responsible for product marketing of Dovetail Genomics kits and services. Prior to joining Dovetail, Iain managed a broad variety of novel technologies including NGS, microarray and qPCR related instruments and consumables. Iain completed his Ph.D. graduate work with a focus on gene expression at the European Molecular Biology Laboratory in Heidelberg, Germany, prior to completing a post-doc at the Massachusetts Institute of Technology in the cell cycle biology field.
                                                    • Scott H. Soderling, PhD
                                                      Founder and CSO, CasTag Biosciences Chair and Professor of Cell Biology, Duke University
                                                      Biography
                                                        Scott Soderling's laboratory at Duke University is focused on unlocking the molecular composition of key neural cell structures to discover how proteins implicated in brain disorders function to govern diverse cellular properties underlying behavior. Utilizing novel proteomic, genome engineering, and neural circuit approaches developed in-house, they functionally link how perturbations to neural proteomes alter brain function relevant to neurodevelopment and psychiatric disorders. These models are being used to dissect a large numbers of candidate genes whose disruptions lead to critical perturbations in protein function underling disorders such as Autism, Intellectual Disability, and Schizophrenia.
                                                      • Jason G. Underwood, PhD
                                                        Principal Scientist
                                                        Biography
                                                          Jason G. Underwood, Ph.D is Principal Scientist for PacBio, specializing in molecular biology. After doctoral and postdoctoral training in RNA biology, Dr. Underwood joined PacBio in 2010 and developed the first protocols for PacBio's long read RNA-seq product known as Iso-Seq or isoform sequencing to read full length mRNAs. More recently, he has focused on technology development, adapting the Iso-Seq methods to target specific gene families or to capture full length mRNA sequences with single cell resolution.
                                                        • Stephen Williams, PhD
                                                          Senior Computational Biologist, 10x Genomics
                                                          Biography
                                                            Stephen Williams is a Senior Computational Biologist at 10x Genomics. Prior to joining 10x Genomics, she was an Assistant Professor at University of Virginia. He received a Ph.D. in Human and Molecular Genetics at Virginia Commonwealth University where he studied the genomic and molecular causes of intellectual disability syndromes such as Smith-Magenis Syndrome.
                                                          • Kris C. Wood
                                                            Assistant Professor, Department of Pharmacology and Cancer Biology, Duke University
                                                            Biography
                                                              Kris C. Wood, Ph.D., is an Associate Professor in the Department of Pharmacology and Cancer Biology at Duke University. He received his B.S. degree in Chemical Engineering from the University of Kentucky, where he was recognized with the outstanding sophomore, junior, and senior awards in Chemical Engineering, the Tau Beta Pi outstanding senior award in the College of Engineering, and a Barry M. Goldwater scholarship in science and mathematics. He received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology, where he developed self-assembling polymeric systems for controlled gene and drug delivery under the supervision of Professors Paula Hammond, Ph.D. and Robert Langer, Sc.D. As an NIH and Misrock Fund postdoctoral fellow in the laboratory of David Sabatini, M.D., Ph.D. at the Whitehead Institute for Biomedical Research and the Broad Institute of Harvard and MIT, his work focused on the development of functional genomic tools to study the determinants of anticancer drug sensitivity. Kris' lab at Duke, founded in 2012, focuses on two related themes: (1) identifying, mechanistically characterizing, and translating new, molecularly targeted therapeutic strategies for biomarker-defined cancer subtypes and (2) defining rational strategies to control long term tumor evolution. To power these studies, Kris' team develops and adapts a range of new functional genomic technologies. The lab's work has been recognized by early career awards from the Ovarian Cancer Research Fund Alliance, the V Foundation, the Stewart Trust, the Forbeck Foundation, the Whitehead Foundation, and the NIH BIRCWH Program. It has also inspired the design of multiple ongoing clinical trials and the creation of three biotechnology companies: Celldom (Silicon Valley, CA), Tavros Therapeutics (Durham, NC), and Element Genomics, now a wholly owned subsidiary of UCB Pharma (Brussels).
                                                            Sponsored by

                                                            For information on becoming a sponsor or exhibitor, please click here.


                                                            Posters

                                                            Posters

                                                             

                                                            POSTER SUBMISSION GUIDELINES

                                                            Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.  If you are interested in sponsoring a Poster for this virtual event and generate leads, the cost is $250 and you can submit the poster at advertise@labroots.com.


                                                            SUBMIT YOUR ABSTRACT

                                                            Enter the following information to this Submission Form:

                                                            • Poster Title
                                                            • Your Name
                                                            • Your Institution
                                                            • Your Email
                                                            • Abstract describing the poster


                                                            All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                                                            If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                                                            Questions? Email Posters@LabRoots.com

                                                            LabRoots Policy

                                                            C.E. Credits

                                                            The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                            Committee

                                                            To download the Program Committee brochure here.


                                                            • Shawn Baker

                                                              Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                                              See more See less
                                                            • Agnieszka Caruso

                                                              Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                              See more See less
                                                            • Sarah Elsea

                                                              Dr. Sarah H. Elsea is an Associate Professor of Molecular and Human Genetics at Baylor College of Medicine and is Senior Division Director of Biochemical Genetics at Baylor Genetics. Dr. Elsea earned a B.S. in chemistry from Missouri State University and Ph.D. in biochemistry ...

                                                              See more See less
                                                            • Emily Hollister

                                                              Dr. Emily Hollister is a microbial ecologist and serves as the Vice President for Information Technology & Analytics at Diversigen, Inc. Prior to joining Diversigen, Dr. Hollister served as an Assistant Professor in the Department of Pathology & Immunology at Baylor College of ...

                                                              See more See less
                                                            • Mark Kiel, PhD

                                                              Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was ...

                                                              See more See less
                                                            • Jonas Korlach

                                                              Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...

                                                              See more See less
                                                            • Tatjana Matejic

                                                              Tatjana is an immunologist with more than two decades of experience working at biotech and pharma companies from start-ups to large global corporations ( Pfizer,Inc. being the latest), contributing significantly to team efforts and successes of more than thirty early and clinical ...

                                                              See more See less
                                                            • Molly McGinniss

                                                              Molly McGinniss, MS, LCGC is a Senior Market Development Manager for Illumina's "Healthy Genome Initiatives" team. Her current role focuses on advancing the use of whole genome sequencing in clinical care by providing access and education to healthy individuals through the ...

                                                              See more See less
                                                            • Fritz Sedlazeck

                                                              Dr. Fritz Sedlazeck completed his PhD in 2012 in the group of Dr. Arndt von Haeseler at the Max F. Perutz Laboratory in Vienna. After a two year postdoc, he transitioned to the lab of Dr. Michael Schatz at Cold Spring Harbor Laboratory and later to Johns Hopkins University. Since ...

                                                              See more See less
                                                            • Khyati Shah

                                                              Khyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...

                                                              See more See less
                                                            • David Smith, PhD

                                                              David I Smith received his B.S. in Mathematics and Molecular Biology from the University of Wisconsin in Madison. He then received his Ph.D. for the Department of Biochemistry also at the University of Wisconsin in Madison. After several postdoctoral positions he got his first ...

                                                              See more See less
                                                            • Tao Wu

                                                              Dr. Tao Wu received his B.S. from Nankai University a leading academic institution in China. In his last year at college, his reading of "What Is Life? The Physical Aspect of the Living Cell" (by physicist Erwin Schrödinger, 1944) inspired him to pursue a career in deciphering ...

                                                              See more See less
                                                            Help

                                                            General LabRoots Questions

                                                            email support@labroots.com  

                                                            Virtual Events and Webinars

                                                            Supported Configurations

                                                            • Operating System Internet Explorer Firefox Chrome Safari
                                                              Vista IE8+ FF10+ Chrome15+
                                                              Windows 7 IE8+ FF10+ Chrome15+
                                                              Windows 8 IE10 FF10+ Chrome15+
                                                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                            • Cookie settings: session cookies enabled
                                                            • Browser configuration must have JavaScript enabled
                                                            • Adobe Flash player 10.2 or later

                                                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                            Internet Connection

                                                            • A minimum of 100Kbps is recommended for audio-only events
                                                            • A minimum of 300Kbps is recommended for speaker on-video events

                                                            Computer Equipment

                                                            • Screen Resolution: Minimum 1024x768
                                                            • Video Card: 65,000 colors minimum
                                                            • Sound card and speakers (or headphones) for hearing webcast in full format
                                                            • Audio Card: 16-bit minimum
                                                            • RAM: 512MB of free RAM

                                                            Firewall Protocol

                                                            • HTTP on port 80 or HTTPS on port 443
                                                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                            Work-At-Home Attendees

                                                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                            For A Seamless Experience

                                                            When using a mobile device, FREE Mobile Apps are available:

                                                            - For viewing Webinars:

                                                            - For viewing Virtual Events

                                                            Attendee Guide

                                                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                            Virtual Event and Webinar Support:

                                                            Continuing Education (CME/CE) Support

                                                            Loading Comments...
                                                            Show Resources
                                                            Attendees
                                                            • See more